Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NASDAQ

NASDAQ

posted on May 05, 2008 09:07AM

With the exception of the recent appointees, the BoD make-up was self-serving ie protecting their own assets. It is my belief that the closer PTSC is to M&A the less the reason for those appointees to remain.

Goerner is not a fool and he will be applying reasoned pressure to those members, in my very humble opinion, for their resignations prior to any NASDAQ application/listing, as well as the inclusion of at least one independent director.

From the uncertainty at the time of their initial appointments, to the now more secure footing of PTSC, it must be obvious to even them that it is time to hand over to the professionals who will move the Company to the next level. The current status of PTSC, I suggest, therefore makes their appointments redundant, and I do not forsee all of them standing for re-election in October.

It is not about what needs to be done as an OTCC BB stock, but the best solution for a prospective NASDAQ company.





Be well

Share
New Message
Please login to post a reply